Back
Automatically translated version. May contain inaccuracies compared to the original.
The Fistal oncology empire: 231 million, 200 million bail, and no convictions. Imagine a mechanism in which state funds meant for treating Ukrainian cancer patients flow for years into the circle of a single family. Not through secret offshore accounts, but through ordinary tenders for equipment for the National Cancer Institute.
This is exactly the picture recorded by NABU in criminal proceeding No.52021000000000596, and it is why on 19 June 2025 VAKS set bail for the defendant at 200 million hryvnias. This is one of the largest bails in the history of Ukrainian anti-corruption justice, and it concerns Herman Fistal, whom the investigation considers the scheme’s organizer.
According to NABU and the SAP, in 2021 and 2022 the National Cancer Institute purchased medical equipment at inflated prices.
The difference between the real and the tender price reached 50%. Within the case, detectives recorded the seizure of more than 231 million hryvnias from the budget, and the list of suspects formed around several key figures.
🔸Yurii Vasylenko, director of LLC “Ortoimpex.”
🔸Oksana Chulup, deputy director of LLC “Dyspomed,” whom the prosecution explicitly calls the “right hand”
🔸Dmytro Kaliushchenko, secretary of the institute’s tender committee.
🔸Bohdan Borysiuk, head of the procurement working group.
🔸Andrii Shypko, former head of the institute, now a deputy of the Dnipropetrovsk Regional Council.
Oksana Chulup was released on bail of 50 million hryvnias, and courts have since extended her procedural obligations eight times.
The most recent extension was recorded on 22 July 2026 and is effective until 10 September. That means the case has not only not collapsed, but is systematically expanding. On 13 August 2025 NABU and the SAP released parts of wiretap materials which, they say, confirm Fistal’s involvement in coordinating purchases.
⚖️ The VAKS Appeals Chamber 30 June 2025 left the bail at 200 million hryvnias unchanged, rejecting the defense’s complaint.
Herman Fistal appears as the ultimate beneficiary of several companies that have worked with the budget for years.
✔️“Avtospetsprom” (38183310)
✔️“Dyspomed” (32250962)
✔️“NVK Kras” (38183326)
✔️“Dopomoga-I” (32395558)
✔️“Region 2002” (32214495)
✔️“Expert Pathomorphological Laboratory” (39224951)
✔️“Umedo Group” (39022461)
✔️“Vayer Medtekhnika” (32395570)
✔️“RVK.RVS.” (35039932)
The total amount of state funds that passed through companies with Fistal’s direct beneficiary ownership, according to Our Money’s estimate, exceeds 5 billion hryvnias.
If one adds the broader circle of 16 companies that regularly acted as counterparties or co-performers, the sum approaches 12,6 billion hryvnias of state procurement.
At the same time, none of these figures are currently a court verdict. These are investigative materials, public tender data, and decisions on preventive measures. But the scale matters in itself, because 200 million in bail and 231 million in established damages are not a minor administrative matter, but the threshold of the highest-level criminal liability.
🔍🧡🧡🧡🧡🧡🧡
is following this story step by step, because it is a rare case when anti-corruption bodies did not stop at one episode, but systematically maintain oversight over an entire business group.
The next step belongs to the courts. And it will determine whether the Fistal oncology empire becomes a story of holding people accountable, or another case halted halfway.
Document: PDF proof of the original version of the news item "Онкоімперія Фісталів: схема 231 млн гривень та жодного вироку". It records the publication content at the moment of the first scan, the preservation date and the source: 368.media.
